Peer-reviewed article
Critical pertussis infection in the paediatric intensive care unit: A case series in an outbreak.
Crichton H, Nkado N, Morrow B, Salie S, Procter C ·
Summary
Written by AI, not yet AICS's view · claude-haiku-4-5-20251001This study examines 19 children with critical pertussis admitted to a South African intensive care unit over one year, of whom 7 died. Most affected children were unimmunised infants under 3 months old. HIV-exposed infants, preterm babies, and those with septic shock or acute kidney injury had worse outcomes. The findings highlight the need for stronger vaccination programmes, including maternal vaccination during pregnancy.
Key points
- Of 1,273 PICU admissions, 19 tested positive for pertussis (1.5%), with 68.4% completely unimmunised
- Mortality rate was 36.8% (7 deaths among 19 infected children)
- HIV-exposed patients had higher mortality (42.9% vs 25%) and preterm infants had higher mortality (57.1% vs 33.3%)
- All children who died had septic shock, compared to 57% of survivors
- Significantly higher white cell counts were associated with mortality
Limitations
This is a small case series from a single centre over one year, so findings may not be generalizable to other settings. The study cannot establish causal relationships or identify universal predictors of mortality, as no variable was independently associated with death in multivariable analysis.
Abstract
Background Bordetella pertussis is a highly infectious disease associated with increased mortality in young infants. Critical pertussis is defined as pertussis disease resulting in paediatric intensive care unit admission or death. Objectives This study describes the clinical profile, morbidity, mortality and management of children with critical pertussis admitted to a South African paediatric intensive care unit (PICU). Study design A retrospective analysis of children with critical pertussis admitted to the PICU over 1 year (January 2022 - December 2022). Results There were 1 273 PICU admissions during the study period, of which 101 (7.9%) were tested and 19 (1.5%) tested positive for B. pertussis. Of those, 13 (68.4%) were completely unimmunised, mainly owing to young age (n=9). The median (interquartile range) total duration of ventilation was 7.0 (3.0 - 21.0) days, with a maximum of 35 days. Mortality was 36.8% (n=7) in those with B. pertussis; with more deaths in HIV-exposed patients (n=3/7,42.9% v. n=3/12, 25%; p<0.001) and preterm infants (n=4/7,57.1% v. n=4/12, 33.3%; p<0.001), as well as those with septic shock (n=7/7, 100% v. n=4/7, 33.3%; p = 0.02) and acute kidney injury (n=6/7, 85.7% v. n=2/12, 16.7%; p<0.001). The maximum white cell count was significantly lower in survivors (27.75 v. 76.32; p<0.001). None of the variables was independently associated with mortality on multivariable regression. Conclusion Critical B. pertussis infection is associated with significant morbidity and mortality in this setting. The low rate of vaccination is a concern, and advocacy is needed to promote access to vaccination during the third trimester of pregnancy as well as strengthening current immunisation programmes. Further research is required to identify the prevalence of critical pertussis and risk factors for poor outcomes in resource-limited settings. Contribution of the study This study demonstrated high mortality rates in infants with critical pertussis under the age of 3 months, especially in infants who are unimmunized or partially immunized. We therefore recommend vaccination against Bordetella pertussis in the third trimester of pregnancy and stress the importance of strengthening current immunization programmes. Our study highlights the importance of describing the markers of disease severity, such as hyperleukocytosis, especially in resource constrained settings, in order to ensure timeous transfer to PICU. We recommend further research regarding these markers of disease severity as well as therapies offered such as leukoreduction or exchange transfusion.
Findings the Hub has extracted
Each claim below is labelled by its type of design and links back to this report.
- Intervention
- Vaccination against Bordetella pertussis (including recommended third trimester maternal vaccination) and strengthened immunisation programmes
- Population
- Infants and young children, particularly those under 3 months, in a South African PICU setting
Key finding
68.4% of children with critical pertussis were completely unimmunised